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In this manuscript, I shall take a clinical ap-
proach to the pathogenesis of recurrent herpes 
simplex which I sha ll d iscuss under five headings: 
(1) What a re the clinical cha racteristics which 
must be expla ined by theories of pathogenes is of 
recurrent herpes simplex? (2) What determines t he 
location of t he recurrent sites? (3) What precipi -
tates recurrent herpes? (4) Where does the virus 
reside in the quiescent interval between recur-
rences? (5) What is the role of immunolog ic sur-
veillance in precipitation and healing of recurrent 
herpes? 
WHAT ARE THE CLI N ICAL CHARACTERISTICS 11 -61 
WHICH MUST BE EXPLA1NED BY T HEORIES OF' 
PATHOGENESIS OF' RECURRE T H ERPES SIMPLEX? 
Prodrom al itching or burning is often the first 
evidence of a recurrence, a nd neura lgic pain is 
occasionally noted to precede or accompany t he 
eruption. Grouped ves icles which se ldom become 
larger than a few millimeters and con ta in la rge 
amounts of infectious virus develop at the recur-
rent site. The ves icles a re in traepidermal and 
contain inf1ammatory cells and infected epidermal 
cells which show ballooning, intranuclear inclu -
sions, and multinucleated giant -cell formation. 
An impor tant feature is t hat recurrences take 
place near the same site. They may occur at 
exactly the same site or they may wander a round 
some and recur in the same general anatomic 
area. Frequently, a pigmented spot marks the 
site of a preceding recurrence. Mul t ipfe recur-
rent les ions may be seen, somet imes at widely 
separa ted sites and wi th individua l sites in or out 
of phase with eac h other. I have seen a girl with 
eleven sites of recurrent herpes including bilateral 
lesions of the face and bilateral recurrent kerato -
conjunctivitis. It is not uncommon to see patients 
with two or t hree recurrent sites which may be on 
t he face , geni ta li a, buttocks, and thighs. Recurrent 
lesions not in frequent ly appear on both sides of the 
midl ine, espec ia lly when the lips, geni ta l area, a nd 
sacrum are involved. 
Individua l ves icles in a group a nd t he group 
itself reach maximum size in a few days and hea l 
rapid ly in a week or two, usua lly without scarring. 
Infectious virus di sappears ra pidly with hea ling. 
Although a type of viral celluli t is, lymphangitis, or 
lymphadeniti s may deve lop in some patients , re-
currences are usua lly assoc iated with few or no 
regiona l or systemic symptoms, in contrast to 
primary infections. The completely unpredictable , 
recurren t course of the disease makes eva luation of 
therapeutic measures very difficul t. For no appar-
ent reason , recurrences may cease for months or 
years and then start up again just as myste riously. 
The most common sites of recurren t herpes of 
the skin are the face and neck. Next comes the 
anogeni tal area and t hen the'sacruni and buttocks . 
However, recurrent herpes can be seen anywhere 
on the skin surface including the ea rs, nose, chest, 
abdomen, arms , palms , dorsa of t he hands, fingers, 
thighs, and legs. I once saw a patient with recur-
rent herpetic les ions under a fingerna il. Other 
common s ites of recurrent herpes are t he eye and 
cervix. The mouth , respiratory tract, and central 
nervous system a re less often involved with clini -
cally evident recurrent disease. 
Since recurrent herpes is produced by both type 
1 and type 2 virus and t he recurrences ap pear to 
behave t he same with either type, I sha ll not go 
into a discussion of the differences a nd simil arities 
between the man ifestations of in fections with 
these two ty pes of herpesvirus. The patient may be 
infected with both types and have recurrences 
caused by eit her or both. 
WHAT DETERMINES T HE LOCATION OF' THE 
RECURRENT SITES? 
The site of the prima ry infection is determined 
by ini t ial exposure to the virus. The recu rren t site, 
in turn , appears to be determined by t he location 
of t he primary infect ion [2- 5 ]. The most frequent 
sites of recurrences are, in general, t he most 
frequent sites of primary infections. In addition, 
many physicians have documented primary in fe c-
tions which have been followed by recurrences 
weeks or months later at t he same site. This is 
especially convincing in those cases where t he 
primary lesion has been on t he finger or some site 
which can be easily observed [7 ]. We have seen 
physicians, medica l students, a nd nurses who have 
had primary infect ions of the fingers fo llowed by 
episodes of recurrent herpes at the sites of primary 
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recurrent les ion a t t he injection s ite [4,5,8] . Much 
work of t his type was done on humans in Europe in 
the 1920s and 1930s and some was done in t his 
country in t he 1940s, 19505, and later. It was 
popula r a few years ago to inocula te virus from a 
penil e lesion into the sa me patien t's arm in hopes 
of enhancing his " immunity" to the virus and 
ameliorating his penile herpes. It a ppea rs that a ll 
that was accomplished in most cases was t he 
esta blishment of a new recurrent s ite on t he a rm . 
WHAT PRECIPIT ATES RECURRENT HERPES? 
The fa ctors t hat seem to prec ipi tate recurrent 
herpes wi th greatest regu lari ty are sunburn , febrile 
illnesses, artificially induced fever, manipul ation 
of the t ri gemina l nerve, and sexua l activit ies 
[3-6,9 ]. Ot her precipitating factors are ha rder to 
document, including menses, emotional stress, 
heat , foods, drugs , heterologous serum injections, 
a nd pneumoencephalograms. Al t hough a type of 
reactivation herpes t a kes pl ace in t he eye or 
nervous system of animals in response to an Art hus 
reaction, anaphylax is, and administration of epi -
nephrine [1 ,2,4,5 ], an experimental model in ani -
mals for t he ty pe of recurrent herpes t hat occurs in 
man is lacking at t his time, espec ially a model for 
recurren t herpes of the skin . * 
Prec ipitat ion of Recurren t Herpes by S unburn 
It is "common kn owledge" t hat sunburn prec ipi -
tates herpes. Usua ll y .light- induced herpes appea rs 
on the face in the a rea innervated by the t ri geminal 
n erve and t he virus isolated is type 1. Des pi te t he 
com mon occurrence of recurren t herpes a fter sun -
burn , I have been unable to find any experimenta l 
data on t his subject fo r man and very .li ttle for 
a nim als (10]. ' I know that some dermatologists 
have studied t his problem in humans but a ppa r-
ently t he ir findin gs have not been published or I 
have missed t hem . 
We have done a study of t hree pat ients which I 
report here as a pilot study. Two had recurrent 
herpes of t he buttock and one of the t high. All were 
treated wi th ul t rav iolet light from a clinical H a-
novia hot qua rtz lamp during t he quiescent, hea led 
period of t he di sease. Herpes was prec ipi tated in 
t he three patients in four of nine attempts giving 
4.5 to 8 minimal erythema doses of ul t raviolet 
light. Itching or redness a ppeared in 2 to 5 days 
and vesicles appea red in 3 to 5 days . The herpes 
was mild on two occasions a nd unusua lly severe on 
two occas ions . T ype 2 virus was isolated from all 
four recurrences. Of t he five fa ilures, on two 
occas ions there was mild erythema due to a low 
dose of ul t rav iolet ligh t and on ' two occas ions 
patients had been treated at the same sites 4 and 6 
weeks earli er and probably had some protection 
aga inst the li ght. T o prec ipi tate herpes ex peri-
* S ince t hi ta lk was given, a pa per has bee n pub-
I ish ed (lnrect Immun ity 12: 162- 165, 1975) which in-
dicates t hat a m od el resemb ling recurrent herpes in 
ma n may be deve loped in gu inea pigs . 
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menta lly, we would suggest the administration of 8 
minimal erythema doses of ul t rav iolet to a 3- inch 
diameter cicle centered over a hea led recurren t 
s it e . 
Admi t tedly, this is a sma ll number of pat ien ts so 
t hat our resul ts a re not conclusive. It might a lso be 
argued that heat rather t han light p rec ipi tated t he 
herpes. Our thermocouple readings did s how that 
the "sunburned a reas" were wa rmer t ha n t he 
surrounding areas by 1 to 2 cC during t he peak of 
erythema. 
Precipitation of Recurrent Herpes by Feuer 
Recurren t herpes has been assoc iated wi t h a 
number of fe brile disorders fo r many yea rs, hence 
the nam e " fever bliste rs." During t he 1930s and 
1940s, artificially induced feve r was used in t he 
trea tmen t of genera l pa res is and other diseases. 
Much information is provided by two artides pub-
lished in the 1940s [11 ,12 ]. F ever was induced by 
diathermy, infra red bulbs, blankets, and water 
baths. The herpetic eruption was usua lly re-
strict ed to the distribution of t he mandibular and 
maxillary branches of the t ri geminal nerve. 0 
herpes was observed below the neck. Approxi-
mately 70% of fever-treated pat ients developed 
herpes. The duration of t he fever seemed less im-
portant than the degree. The herpeti c erupt ion 
usually appeared 24 to 48 hours a fter the induction 
of fever. About 56% of the patients developed 
herpes after the first treat ment , 5 to 20% after 
the second, and a few developed herpes with later 
treatments. If t he , initial fever was between 39 and 
39.5 ce, about 55% got herpes. If the ini t ia l fever 
was between 40.8 and 41 cC, about 86% got herpes. 
This fi gure, 86%, approximates the percentage Of 
persons in t he general population who would have 
antibodies to the virus as evidence of past infec-
tion . It suggests t hat almost everyone who has 
been infected wi th the herpes virus can be made 
to develop herpes if the stimulus is strong enough. 
Mention was made in one of the articles t hat local 
heat to the face had produced herpes of the face, 
but I have not seen this documented experimen-
tally . 
A few yea rs ago we attem pted to use a t issue 
culture model to duplicate the effects offever [1 3]. 
We incubated herpes- in fected HeLa cell cul tu res at 
different temperatures. Cul tures kept at 35 ce 
produced t he most virus. Cul tures at 30°C pro-
duced a lot less virus and released li ttle in to t he 
cul ture medium . Cul t ures could be kept at 25°C 
for seve ral days with li tt le or no ev idence of virus 
production . Cul tures kept at 25 cC could be in -
duced to produce virus prompt ly by ra is ing t he 
temperature of incubation to 35°e . These experi -
ments demonstrated t hat some process or proc-
esses in t he production of herpes s implex virus are 
te mperature dependent, but t his is true of a 
number of viruses. What t his ex perimenta l phe-
nomenon has to do with precipitation of recurrent 
herpes by fever in man rema ins to be determined. 
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Precipitation of Recurrent Herpes by 
Manipulation of the Trigeminal Ne;'ve 
Several reports over the past 70 years have 
indicated that surgery of t he tr igemina l nerve, 
usually for tic douloureux, triggers herpes of the 
face in over ~I:I of the patients [2,4,5 ,14,15]. Herpes 
appears on the sa me side as the surgery . Herpes 
occurs after sect ion of the nerve root proxi ma l to 
the ganglion but herpes does not occur after alcohol 
injection of the nerve or ganglion. In fact, section of 
the nerve distal to the gangl ion or injection of the 
nerve with alcohol may prevent herpes on the face 
after section of the nerve proxi mal to the ganglion. 
Herpes usually occurs only in the area innervated 
by the max illa ry and mandibular branches of t he 
nerve and not the ophthalmic branches (possibly 
because primary infections affect t he ophthalm ic 
branch less often). If a patient has been ope ra ted 
~ upon once for tic douloureux and has an a nesthetic 
area and is operated upon again, herpes may 
appear again , but not in the anesthetic area from 
the prev ious operation. 
These observations led people to believe for 70 
years [14] that virus resided in the t rigeminal 
nerve ga nglion during clin ically inactive herpes 
but this has been proved only recently with more 
advanced tec hniques of culture of the ganglion to 
bring out " latent or inactive" virus [16]. 
WHERE DOES THE VIRUS RESIDE IN THE QUIESCENT 
INTERVAL BETWEEN RECURRENCES? 
Three main theories concerning the location of 
the virus in the quiescent period between recur ~ 
rences have been championed by various investiga-
tors [1 -6 ]: One is that a chron ic infection of the 
mucous membranes and glandular append ages of 
the eye, mouth, or genitalia is established a nd 
serves as a source of virus for clinically evident 
recurrences. The second postulates t hat virus is 
present in some latent, incomplete, or inactive 
form in skin and mucous membrane at t he recur-
rent site. The third says that virus is present in 
some latent, incomplete, or inactive form in nerve 
tissue at a point distant from the recurrent s ite but 
in nerves that innervate the recurrent site. 
Chronic Infection of Mucous Membranes and 
Glandular Appendages 
It may be that chronic herpetic infection is 
established in mucous membranes and glandular 
appendages of the eye, mouth, nose, or genital 
area. Virus is present in tears, saliva, and genital 
secretions from time to time in the absence of 
clinical disease. Such virus could be inoculated 
into the cornea, lip, vu lva, and penile sk in to 
produce herpetic lesions. However, this doesn 't 
explain how virus from mucocutaneous areas could 
be inoculated repeatedly into distant sites on the 
buttocks, hands, or lower legs to produce recur-
rences. For instance, it is inconceivable that a 
patient who has had many recurrences on the lower 
leg could inoculate virus from the mouth, eye, or 
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gen ital area into the same site on the leg repeatedly 
unless th is was purposely done, which is not t he 
case. 
Virus Present in Inactive Form in Sk in 
Since infectious virus is found in sk in during 
active recurrences, it seems reasonable to consider 
that virus resides in sk in in some form during the 
interval between recurrences. In addition, purpose-
ful inocu lation of the virus in to sk in induces a new 
recurrence at the site [4,5,8,17]. Furthermore, it 
is stated in the li terature that exc is ion has " cu red " 
recurrent lesions. However, as far as I can tell, the 
statements about excision are based on work with 
about a half-dozen patients and in some of these 
patients herpes recurred la ter adjacent to the ex-
cised a rea [2,4,5, 18,19]. The observation that loca l 
ultraviolet- light administration precipitates recur-
rent herpes a lso suggests that the virus may be in 
skin although the light (or heat) might serve, in-
stead , to ca ll the viru fo rth from a nerve ganglion 
m some way. 
The biggest argume nt against vi rus being in the 
skin in some form in the quiescent stage is that it 
has never been found there [2,4.5,20,21 ]. How-
ever, one is reminded that it took 70 years to find 
virus. in the tr igem ina l ganglion. Maybe a earch 
for virus shou ld be made again using new tech-
niques applied to skin. 
It is cited that it has not been possible to transfer 
a recurrent s ite by switch ing skin grafts on the 
same pa t ient. As far a I can te ll , this has been 
tried in only two or three patients and thi s was done 
in the 1930s [5,19 ]. This is hardly conclusive. 
Virus Present in Inactive Form in Nerv e Tissue 
Residence of t he virus in some latent or inactive 
form in nerves has been a popular concept for 70 
years [14 ,22] and evidence is accumulating to 
support th is idea. Burning, itching, and neuralgic 
pain suggest that nerves are involved [23]. Rarely, 
herpes takes a zosteriform appearance, suggesting 
location in a nerve. I have discussed above the 
information derived from surgery of the tr igem inal 
nerve which strongly implicates residence of the 
virus in this nerve and its ganglion. 
Other evidence for residence of t he virus in 
nerves follows . Fever induces herpes in the tr igemi -
, nal nerve area. Central nervous system recurrent 
herpes, although not widely discussed, appea rs to 
occur. There is a large body of evidence from 
an imal experimentation over the past 50 years that 
herpes travels along nerves [1 ,24- '29]. For instance, 
it has been known for a long time that if t he sciatic 
nerve is cut soon after inoculation of virus into the 
hind foot, virus is prevented from spreading to t he 
sp inal cord via the sc iatic nerve as it would 
ordinari ly do. Recently, spread of the virus along 
the sciatic nerve has been demonstrated by mod-
ern, sophisticated techniques. Although there is 
still some question, viral spread may be axonal, as 
suggested in the 1920s by Goodpasture [24,25]. 
Recent ly, also, herpes virus has been found in the 
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Gasserian and other gangl ia [16,30- 32 ] of man and 
animals during clinically quiescen t episodas long 
after the ini t ial infection has subsided . The im-
plications are that: (1) virus passes from skin ?r 
mucous membrane via sensory nerves to gangli a 
durinO" t he initia l infection, (2) virus remains in 
ganglia in some quiescent state for var iable periods 
of time unt il something disturbs t he status quo, 
and (3) virus t hen returns via nerves to skin or 
mucous membranes to produce recurrent herpes. 
These are matters for future substant iation and 
experimentation. 
WHAT IS T HE ROLE OF IMMUNOLOG IC 
SURVEILLANCE IN PRECIPITATIO AND HEALING OF 
RECURRENT HERPES SIMPLEX? 
Many people have wondered whether decreased 
im munologic surve illance precipitates recurrent 
herpes [3- 6]. I doubt, however, whether recurrent 
herpes is caused by a te mpora ry waning or la pse of 
immunologic surve illance and my reasons follow. 
Recurrent herpes is a very common disease which 
appears in patients who a re otherwise normal; 
t hese are not immunologic crip ples. So far , no one 
has shown that recurrent herpes is preceded by a 
significant drop in serum a ntibody [5,6 ], comple-
ment, or cellular immunity as measured by lym-
phocyte transformation and skin tests [33-35 ]. 
This work may not be conclusive and I suppose 
that loca l immunity could wane without a change 
in systemic immuni ty, but it seems to me that t his 
is not where the money is. t 
On t he other hand , it appears that immunologic 
mechanisms playa major role in t he hea ling of a 
recurrent herpes s implex lesion once it has ap-
peared. My reasons are based on clinica l observa-
tions. Recurrent herpes of immunosuppressed pa-
tients is asso'ciated with persistent, large, deep, 
widespread , or bizarre lesions as seen in pat ients 
with lymphomas, Hodgkin 's disease, leukemias, 
renal transplants, Wiskott-Aldridge syndrome, 
immunosuppress ive drugs, ant ilymphocyte se rum , 
and terminal debili ty [36-38]. I am not sure t hat 
these patients develop recurrent herpes more often 
than other patients, but it seems certain that when 
they do develop herpes, healing is delayed . In 
addit ion, herpet ic infections, often primary infec-
tions, a re poorly cont rolled in patients with exten-
sive burns, severe starvat ion, prematurity and the 
newborn state, after measles, in thymic aplasia, or 
after large doses of x-ray [39- 41 ]. 
The exact relative roles of humoral and cellular 
immunity in the healing of recurrent herpes are not 
known bu t it seems likely that both playa part and 
that t hey compliment each other. The fact that 
agammaglobulinemic patients usually handl~ the 
disease well unless they also have a cell -med18ted 
immune defect suggests t hat humoral immunity is 
the least important of these two [42 ]. In patients 
t A paper published since this ta lk was given .(lnfect 
Immunity 12: 76- 80, 1975) presents eVidence (or de-
creased lym phocyte fun ction in patients with recurrent 
herpes. 
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with well-established recurrent herpes, t here are 
high t iters of serum ant ibod ies to t he virus as 
measured by neutra li zation and complement-fixa-
t ion tests. Serum antibodies may serve to keep the 
infection loca lized but t hey do not prevent recur-
rences. Complement enhances neut rali zation of 
the virus under some circumstances in vitro. In 
some models, antibodies appear to be formed to 
ce lls whose surfaces have been antigenically and 
specifically altered by t he viral infection [43- 45]. 
In addition, an t ibodies inhibit viral spread in 
tissue-culture models. 
Some time ago we nourished herpes-i nfected 
tissue cul tures with medium which contai ned vary-
ing a mounts of serum anti bod ies [46 ]. In antibody-
free medium, the infection spread rapidly, pro-
duced a la rge a mount of virus, and destroyed the 
cul t ures in about 10 days. When a large amount of 
serum antibody was present in t he medium , t he 
cultures survived over long periods but there was 
always virus to be found in some of the cells of t he 
cul t ures. Apparently uninfected ce lls proliferated 
and kept the cultures go ing. The virus spread from 
cell to cell and was always present but could not 
kill t he cul tu res. Antibody did not eliminate t he 
virus but protected t he cells enough so t hat a 
stable condi t ion was produced and the infected 
cultures could apparently be kept going indefi-
nitely. S imilar models, except for their short-term 
features, are now being used by a number of 
invest igators to study t he effects of drugs, biologi-
cals, and immune cells on herpes infections in vitro 
[43,44,47 ]. 
Regard ing t he role of cell -mediated immunity in 
recurrent herpes s implex, it has been known for a 
long ti me t hat patients with recurrent herpes have 
posit ive skin tests of t he delayed type to herp'es 
virus. I have a lready pointed out that recurrent 
herpes is handled poorly in patients with diseases 
with defi cient cell -mediated immunity. Positive 
lymphocyte stimulation to herpes virus has been 
shown recently by cell s ta ken from patients with 
recurrent herpes [33-35,45 ]. In addition , in man 
and animals, herpes anti gen stimulates spec ifica lly 
sensitized cells; lymphokines of cytotoxic, chemo-
tactic, and other types are produced by stimulated 
cells ; and specific immune ce lls have been shown 
to destroy herpes- infected cells [32-35,44,48,49 ]. 
There are undoubted ly many other fa ctors at 
work , both immune and nonimmune, such as 
interferon, phagocytos is, intracellular killing, ch~ ­
motaxis, interference with intracellula r metaboli c 
processes, etc., bu t these are out of the province of 
this presentation. 
SPECULATIONS 
One wonders why herpetic vesicles reach a few 
millimeters in size , stop growing, and t hen heal. 
One could dream up a scheme to expla in t his. 
Virus could become active in a single epidermal 
cell. New virus produced by this cell could spread 
to adjacent cells by cell-to-cell spread even in t he 
presence of intercellular antibodies. When enough 
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cells are infected and die, an in trae pidermal blister 
fo rms . Infected cells develop virus-induced a ltered 
cell surfaces. This alteration takes place before new 
infectious virus is produced [44]. After the process 
reaches a certain size , antibodies, complement, 
and immune cells (lymphocytes and macrophlir;es) 
come into the area. Antibodies neutra lize free virus 
and attack specifically altered surfaces of infected 
cells. Immune cel ls and antibod ies destroy infected 
cells before they can produce new virus. The les ion 
heals. This is much too simplistic since it ignores 
t he roles of nonimmune cells, interferon , chemo-
taxis , hepa rinoids, etc., but it provides a frame-
work for further considerations. 
A further scheme in the pathogenesis of recur-
rent herpes can be considered. Th primary infec-
tion invokes cellula r and humoral immunity which 
causes the lesion to heal clinically. During the 
process, virus is not completely eradicated; it 
becomes entrenched in a protected site or in an 
inactive, latent, or incomplete form [4] in nerve 
ganglion (the most likely site), skin, or elsewhere 
which determines the location of a future recurrent 
lesion. Nonimmunologic condit ions such as fever , 
s unburn, or nerve manipulation upset the equilib-
rium somehow . Virus either returns to skin or 
mucouS membrane from a dis tant site such as a 
nerve ganglion or it becomes active at the site 
where it has been inactive all along. An active 
recurrent lesion develops. Immune mechanisms 
cause healing but virus is not eradicated and the 
process repeats itself. 
EPILOGUE 
Dr. Sams asked me last year if I was going to give 
a philosophical or a scientific talk. As befits t he 
image of a "president," I have given a " phi losophi-
cal" talk. I have tried, in a disguised way, to point 
out that clinical observations can often be helpful 
in basic science studies of a biologic problem. I 
have emphasized that clinica l observations may 
antedate and anticipate basic sc ience findin gs by 
many years. Clinical studies often lend proper 
perspective to basic studies. Basic science and 
clinical investigation wi ll go further if they go 
together. The herpes prob lem amply ill ustrates 
these interactions . 
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